Vivo Opportunity funds buy 20,546 InMed shares
Vivo Opportunity–affiliated entities reported open-market purchases totaling 20,546 Common Shares of InMed Pharmaceuticals Inc. at $1.55 per share on July 14–16, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vivo Opportunity–affiliated entities reported open-market purchases totaling 20,546 Common Shares of InMed Pharmaceuticals Inc. at $1.55 per share on July 14–16, 2026. The trades, made through Vivo Opportunity Fund Holdings, L.P. and Vivo Opportunity Cayman Fund, L.P., brought their holdings to 743,057 and 75,019 shares, respectively. Vivo Opportunity, LLC and Vivo Opportunity Cayman, LLC, as general partners, disclaim beneficial ownership beyond their pecuniary interests.
Insider Trade Summary
Net Buyer: 20,546 shares
Net Buy
6 txns
Insider
Vivo Opportunity, LLC, Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Cayman, LLC, Vivo Opportunity Cayman Fund, L.P.
Role
10% Owner | 10% Owner | 10% Owner | 10% Owner
Bought
20,546 shs ($32K)
Increase in Position
2.6%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Shares F1 | 19 | $1.55 | $29.45 |
| Purchase | Common Shares F2 | 2 | $1.55 | $3.10 |
| Purchase | Common Shares F1 | 13,761 | $1.55 | $21K |
| Purchase | Common Shares F2 | 1,389 | $1.55 | $2K |
| Purchase | Common Shares F1 | 4,882 | $1.55 | $8K |
| Purchase | Common Shares F2 | 493 | $1.55 | $764.15 |
Holdings After Transaction:
Common Shares — 743,057 shares (Indirect, By Vivo Opportunity Fund Holdings, L.P.);
Common Shares — 75,019 shares (Indirect, By Vivo Opportunity Cayman Fund, L.P.)
Holdings Before and After:
Common Shares, 724,395 to 743,057 shares (Indirect, By Vivo Opportunity Fund Holdings, L.P.);
Common Shares, 73,135 to 75,019 shares (Indirect, By Vivo Opportunity Cayman Fund, L.P.)
Footnotes (2)
- F1. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- F2. Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P., the record holder of the securities. Vivo Opportunity Cayman, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Key Figures
Total shares purchased: 20,546 shares
Purchase price: $1.55 per share
Holdings – Vivo Opportunity Fund Holdings, L.P.: 743,057 shares
+2 more
5 metrics
Total shares purchased
20,546 shares
Aggregate open-market Common Shares bought on July 14–16, 2026
Purchase price
$1.55 per share
Price for each reported Common Share transaction
Holdings – Vivo Opportunity Fund Holdings, L.P.
743,057 shares
Common Shares held after July 16, 2026 purchases
Holdings – Vivo Opportunity Cayman Fund, L.P.
75,019 shares
Common Shares held after July 16, 2026 purchases
Number of buy transactions
6
Open-market purchase transactions reported by Vivo Opportunity–affiliated entities
Key Terms
open-market purchase, indirect ownership, pecuniary interest, beneficial ownership, +1 more
5 terms
open-market purchase financial
"transaction_action "open-market purchase" for each Common Shares transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
indirect ownership financial
""direct_or_indirect": "I" indicates indirect ownership through the funds"
pecuniary interest regulatory
"disclaims beneficial ownership except to the extent of its pecuniary interest therein"
beneficial ownership regulatory
"shall not be deemed an admission of beneficial ownership of the reported securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
ten percent owner regulatory
""is_ten_percent_owner": 1 for each reporting person"
AI-generated analysis. How Rhea-AI works. Not financial advice.
